Mitchell T. Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mitchell T. Smith has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Brian M. Christenson
Eastern Radiological Associates, Billings, Montana
2 shared publicationsMatthew G. Gipson
Department of Radiology, University of Colorado, Aurora, Colorado
2 shared publicationsAlyn Woods
Department of Radiology, David Grant Medical Center, Travis AFB, California
1 shared publicationBenjamin Rase
Department of Radiology, University of Colorado School of Medicine, Denver, Colorado
1 shared publicationCharles Ray
Department of Radiology, Division of Interventional Radiology, University of Colorado Denver, 12700 E. 19th Ave, Room P15-1205, Aurora, CO 80045
1 shared publicationDavid Thor Johnson
Department of Radiology, University of Colorado, Aurora, Colorado
1 shared publication
Latest Publications
- 2 March 2015
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 32 (01) , 022-025
Skin Necrosis Resulting from Nontarget Embolization of the Falciform Artery during Transarterial Chemoembolization with Drug-Eluting Beads
Intra-arterial embolic therapies are a mainstay of liver-directed therapies to palliate symptoms, improve survival, and bridge patients to transplantation. Vascular anatomy and type of embolic used can lead to complications of nontarget embolization with varying clinical consequences. This case report describes a rare, nontarget embolization of the falciform artery leading to supraumbilical skin necrosis.
- 2 March 2015
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 32 (01) , 022-025
Skin Necrosis Resulting from Nontarget Embolization of the Falciform Artery during Transarterial Chemoembolization with Drug-Eluting Beads
Intra-arterial embolic therapies are a mainstay of liver-directed therapies to palliate symptoms, improve survival, and bridge patients to transplantation. Vascular anatomy and type of embolic used can lead to complications of nontarget embolization with varying clinical consequences. This case report describes a rare, nontarget embolization of the falciform artery leading to supraumbilical skin necrosis.
- 14 November 2014
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 31 (04) , 370-374
Treatment of Infrapopliteal Arterial Occlusive Disease in Critical Limb Ischemia
There is increasing evidence supporting endovascular intervention in patients with critical limb ischemia (CLI) and infrapopliteal artery occlusion where in-line flow to the foot can be reestablished. Patients with CLI due to infrapopliteal arterial occlusive disease are a high-risk group in which the current reported amputation and mortality rates at 1 year are 25% and 20 to 25%, respectively.[1] [2] Treatment of infrapopliteal arterial disease is vital to prevent amputation, relieve ischemic pain, heal lower extremity wounds, and prevent gangrene. Technical success rates are often high (approaching 90%) in infrapopliteal angioplasty, with associated clinical success of approximately 70% in some larger series of patients with CLI.[3] Predictors of a successful outcome include a short occlusion length and minimal vessels or stenoses needing treatment. The updated Trans-Atlantic Inter Society Consensus (TASC)–II guidelines concluded that there is increasing evidence to support the recommendation for angioplasty in patient with CLI and infrapopliteal artery occlusion; lesion length alone is no longer used to determine a recommendation for treatment (as was seen with the TASC-1 guidelines).[1] The following procedure describes our approach to treating infrapopliteal arterial occlusive disease.
- 14 November 2014
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 31 (04) , 370-374
Treatment of Infrapopliteal Arterial Occlusive Disease in Critical Limb Ischemia
There is increasing evidence supporting endovascular intervention in patients with critical limb ischemia (CLI) and infrapopliteal artery occlusion where in-line flow to the foot can be reestablished. Patients with CLI due to infrapopliteal arterial occlusive disease are a high-risk group in which the current reported amputation and mortality rates at 1 year are 25% and 20 to 25%, respectively.[1] [2] Treatment of infrapopliteal arterial disease is vital to prevent amputation, relieve ischemic pain, heal lower extremity wounds, and prevent gangrene. Technical success rates are often high (approaching 90%) in infrapopliteal angioplasty, with associated clinical success of approximately 70% in some larger series of patients with CLI.[3] Predictors of a successful outcome include a short occlusion length and minimal vessels or stenoses needing treatment. The updated Trans-Atlantic Inter Society Consensus (TASC)–II guidelines concluded that there is increasing evidence to support the recommendation for angioplasty in patient with CLI and infrapopliteal artery occlusion; lesion length alone is no longer used to determine a recommendation for treatment (as was seen with the TASC-1 guidelines).[1] The following procedure describes our approach to treating infrapopliteal arterial occlusive disease.
- 1 January 2014
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 25 (1) , 58-62
Risk of Hernia Incarceration following Transjugular Intrahepatic Portosystemic Shunt Placement
- 1 January 2014
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 25 (1) , 58-62
Risk of Hernia Incarceration following Transjugular Intrahepatic Portosystemic Shunt Placement
- 20 November 2013
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 30 (04) , 364-371
Pelvic Vascular Malformations
Vascular malformations (VMs) comprise a wide spectrum of lesions that are classified by content and flow characteristics. These lesions, occurring in both focal and diffuse forms, can involve any organ and tissue plane and can cause significant morbidity in both children and adults. Since treatment strategy depends on the type of malformation, correct diagnosis and classification of a vascular lesion are crucial. Slow-flow VMs (venous and lymphatic malformations) are often treated by sclerotherapy, whereas fast-flow lesions (arteriovenous malformations) are generally managed with embolization. In addition, some cases of VMs are best treated surgically. This review will present an overview of VMs in the female pelvis as well as a discussion of endovascular therapeutic techniques.
- 20 November 2013
- Published by Georg Thieme Verlag KG in Seminars in Interventional Radiology
- Vol. 30 (04) , 364-371
Pelvic Vascular Malformations
Vascular malformations (VMs) comprise a wide spectrum of lesions that are classified by content and flow characteristics. These lesions, occurring in both focal and diffuse forms, can involve any organ and tissue plane and can cause significant morbidity in both children and adults. Since treatment strategy depends on the type of malformation, correct diagnosis and classification of a vascular lesion are crucial. Slow-flow VMs (venous and lymphatic malformations) are often treated by sclerotherapy, whereas fast-flow lesions (arteriovenous malformations) are generally managed with embolization. In addition, some cases of VMs are best treated surgically. This review will present an overview of VMs in the female pelvis as well as a discussion of endovascular therapeutic techniques.